Print Page | Sign In | Join Today
News & Press: Company News

Reckitt Benckiser Pharmaceutical Rebrands Under Indivior PLC Following Demerger

Monday, October 27, 2014  
Share |
Reckitt Benckiser Group plc (RB), UK-based parent company to Reckitt Benckiser Pharmaceuticals Inc. (RBP), expects the proposed demerger of the RBP business to complete in 2014. Reckitt Benckiser originally announced plans to demerge the RBP business in late July 2014, and the operational and financial separations, appointment of the new Board and other activities associated with the demerger have been advanced substantially since that announcement.

As a stand-alone global specialty pharmaceutical company, RBP will leverage its legacy of leadership, passion and expertise in neuroscience to pioneer innovative and accessible therapies for addiction and related mental health disorders. The demerger is anticipated to occur prior to December 31, 2014 following approval of RB shareholders with RBP operating independently under the separate holding company Indivior PLC, which will be listed on the London Stock Exchange.

The name Indivior and tagline "Focus on you" were selected as they aptly embody RBP's vision, mission and values dedicated to transforming addiction from a global human crisis to an actively treated chronic disease. Indivior is the fusion of the words individual and endeavor.

Shaun Thaxter, Chief Executive Officer, Reckitt Benckiser Pharmaceuticals Inc. said, "We had always envisioned a day where our business would reach a point of maturity so we could expand our focus across the chronic diseases of addiction. While great strides have been made within the opioid dependence marketplace, we are well positioned to build on our intimate understanding of the patient journey to combat the broader addiction epidemic and bring to market novel treatment solutions worldwide. From our employees to our leadership team, each and every one of us is inspired and invigorated by the promise this next chapter brings forth for expanding availability of treatment and improving patient lives."

Our Sponsors

Sign up for our newsletter
800 E. Leigh St.  |  Richmond, Va 23219-1534  |  PH: 804.643.6360  |  Email Us
Stay Connected